Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 2446 AL 2460

Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease

Guo M.

Cold Spring Harb Perspect Med. 2012 Nov 1;2(11):a009944. doi: 10.1101/cshperspect.a009944.

Neuroimaging over the course of Parkinson's disease: from early detection of the at-risk patient to improving pharmacotherapy of later-stage disease

Seibyl J, Russell D, Jennings D, Marek K.

Semin Nucl Med. 2012 Nov;42(6):406-14. doi: 10.1053/j.semnuclmed.2012.06.003.

Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia

Nagao S, Yokota O, Nanba R, Takata H, Haraguchi T, Ishizu H, Ikeda C, Takeda N, Oshima E, Sakane K, Terada S, Ihara Y, Uchitomi Y.

J Neurol Sci. 2012 Dec 15;323(1-2):147-53. doi: 10.1016/j.jns.2012.09.005. Epub 2012 Sep 29.

Repetitive step training with preparatory signals improves stability limits in patients with Parkinson's disease

Shen X, Mak MK.

J Rehabil Med. 2012 Nov;44(11):944-9. doi: 10.2340/16501977-1056.

Regional susceptibilities to mitochondrial dysfunctions in the CNS

Pinto M, Pickrell AM, Moraes CT.

Biol Chem. 2012 Apr;393(4):275-81. doi: 10.1515/hsz-2011-0236.

A clinical primer on restless legs syndrome: what we know, and what we don't know

Sethi KD, Mehta SH.

Am J Manag Care. 2012 Aug;18(5 Suppl):S83-8.

Comparison of gait in progressive supranuclear palsy, Parkinson's disease and healthy older adults

Egerton T, Williams DR, Iansek R.

BMC Neurol. 2012 Oct 2;12:116. doi: 10.1186/1471-2377-12-116.

Stem cells for Parkinson's disease: advancing science but protecting patients

Olanow CW, Isacson O.

Mov Disord. 2012 Oct;27(12):1475-7. doi: 10.1002/mds.25170. Epub 2012 Oct 2.

Parkinson's disease and the risk of cerebrovascular pathology

Morley JF, Duda JE.

Mov Disord. 2012 Oct;27(12):1471-2. doi: 10.1002/mds.25179. Epub 2012 Oct 2.

An evidence base for noradrenergic deficits in Parkinson's disease

Halliday G.

Mov Disord. 2012 Nov;27(13):1589-91. doi: 10.1002/mds.25202. Epub 2012 Oct 2.

[Parkinson's disease: current standards in diagnostics and therapy]

Timmermann L, Eggers C, Salimi Dafsari H, Pauls KA, Barbe MT.

Fortschr Neurol Psychiatr. 2012 Oct;80(10):560-9. doi: 10.1055/s-0032-1312738. Epub 2012 Oct 2.

Acute urinary retention increases the risk of complications after transurethral resection of the prostate: a population-based study

Chen JS, Chang CH, Yang WH, Kao YH.

BJU Int. 2012 Dec;110(11 Pt C):E896-901. doi: 10.1111/j.1464-410X.2012.11471.x. Epub 2012 Oct 4.

Association of catechol-o-methyltransferase polymorphism (Val108/158Met) with Parkinson's disease: a meta-analysis

Wang Y, Yang X.

J Mot Behav. 2012;44(5):365-72. doi: 10.1080/00222895.2012.721406. Epub 2012 Oct 4.

MMSE as a predictor of on-road driving performance in community dwelling older drivers

Crizzle AM, Classen S, Bédard M, Lanford D, Winter S.

Accid Anal Prev. 2012 Nov;49:287-92. doi: 10.1016/j.aap.2012.02.003. Epub 2012 Mar 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias